CHAT and Alzheimer disease: Nevertheless, immunoblot analyses were sensitive enough to pick up clear 5xFAD-related reductions in ChAT protein levels in one of the target areas of basal forebrain cholinergic nuclei, namely, the hippocampus, which is consistent with prior studies in transgenic AD mouse models [25–29].